How Can Good Research Practice Guidance Improve Health Technology Assessment?

Published Nov 6, 2017
Glasgow, Scotland, UK—6 November 2017—ISPOR, the professional society for health economics and outcomes research (HEOR), focused on what aspects of health technology assessment (HTA) can be improved with good research practice guidance. The workshop, “Where Do We Need Good Research Practice Guidance in Health Technology Assessment?” [W1], was held this morning at the ISPOR 20th Annual European Congress in Glasgow, Scotland, UK. The session featured discussion leaders Finn Børlum Kristensen, MD, PhD, University of Southern Denmark, Hilleroed, Denmark; Mirjana Huić, MD, PhD, Agency for Quality and Accreditation in Health Care and Social Welfare, Zagreb, Croatia; Wim Goettsch, PhD, The National Healthcare Institute, Diemen, The Netherlands; and Sophie Werkö, PhD, MSc, Swedish Agency for Health Technology Assessment and Assessment of Social Services, Stockholm, Sweden. Post-regulatory approval evidence is increasingly informing population-based health care decisions. In this session, discussion leaders from the ISPOR Health Technology Assessment Council working group began with a global overview of existing good practices related to the translation of evidence to health care policy. Speakers then identified areas in which good research practice guidance is needed and how these areas might best be addressed at the European and global levels. The working group has conducted an overview of existing good practices related to translating evidence to policy from all regions of the world. The draft guidance document has already undergone two rounds of review, including a public review and comment stage. Additional information on the ISPOR 20th Annual European Congress can be found here. Released presentations from the congress can be found here. Interested parties can follow news and developments from the congress on social media using the hashtag #ISPORGlasgow.

###

  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: http://bit.ly/ISPOR-T (@ISPORorg) | YouTube: http://bit.ly/ISPOR-YT | Facebook: http://bit.ly/ISPOR-FB

Related Stories

ISPOR Announces 2025-2026 Board of Directors

May 20, 2025

ISPOR announced the results of its recent elections and its 2025-2026 Board of Directors. The 2025-2026 board will assume office on July 1.

Value in Health Journal Spotlights "Whole Health" in Special Series

May 19, 2025

Value in Health, the official journal of ISPOR, announced the publication of a series of articles exploring the concept of "whole health"—a holistic approach to healthcare that extends beyond the traditional biomedical model to incorporate physical, mental, social, environmental, and spiritual dimensions of wellbeing.

Rethinking Medication Adherence: A Stakeholder Blueprint

May 12, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a report from its Medication Adherence and Persistence Special Interest Group that provides valuable insights into the perspectives of key stakeholders on interventions to improve medication adherence. The report, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report,” was published in the May 2025 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×